The most commonly utilized antifungal was voriconazole, with trends towards better outcomes, although these outcomes did not reach statistical significance [ 22 ].
← all excerpts
Risk Factors and Clinical Outcomes of Invasive Fungal Infections in Patients with Severe COVID-19: A Case-Control Study.
1
—
—